M:__1=!0#0@IYR1C.9'$9&[N%&W
SYSTEM PROCESSING...
M:__1=!0#0@IYR1C.9'$9&[N%&W
SYSTEM PROCESSING...
Posted: 2025-04-24 05:04:59 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 05:05:15 UTC
Verified By
Rollup News
The PARAGON-HF trial revealed that central adiposity, assessed by waist-to-height ratio (WHtR), is almost universally prevalent in heart failure patients with preserved ejection fraction (HFpEF) and is more strongly associated with worse outcomes than BMI. The study suggests WHtR should replace BMI in assessing clinically relevant fat mass in these patients.
Central adiposity is highly prevalent in HFpEF patients.
WHtR is more strongly linked to adverse heart failure outcomes than BMI.
WHtR may be a better measure of clinically relevant fat mass in HFpEF patients.